Phase I study of the novel proteasome inhibitor NPI-0052 in patients with lymphoma and solid tumors Meeting Abstract


Authors: Aghajanian, C. A.; Hamlin, P.; Gordon, M. S.; Hong, D. S.; Naing, A.; Younes, A.; Hannah, A.; Palladino, M. A.; Spear, M. A.; Kurzrock, R.
Abstract Title: Phase I study of the novel proteasome inhibitor NPI-0052 in patients with lymphoma and solid tumors
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 171s
Language: English
ACCESSION: WOS:000208457401044
DOI: 10.1200/jco.2008.26.15_suppl.3574
PROVIDER: wos
Notes: Meeting Abstract: 3574 -- Source: Wos
Altmetric Score
MSK Authors
  1. Paul Hamlin
    170 Hamlin